Neurogan Hemp Oil 500mg is derived from hemp grown in Denmark, yet it’s processed and packaged in the USA. This particular product comes in a pack of three, and Amazon discounts are offered by the manufacturer for higher quantity orders. Since it is not a full spectrum hemp oil, it will not contain CBD. Even so, there are many benefits surrounding hemp seed oil for stress and sleep management due to its Omega-3 and Omega-6 content. Neurogan is a trusted manufacturer, specializing in hemp seed oils. The company is GMP certified, and many customers cite excellent service on their part. They also offer a money back guarantee on their products, which are also lab tested for quality.
Truth be told, one of the biggest draws to using CBD oil for pain has been the fact that it has little distinguishable side-effects or contraindications with other medications. In fact, in a massive report that was published by the World Health Organization during last year’s 2017 Expert Committee on Drug Dependence, it was (finally) declared to the world that CBD is a “safe, well tolerated [compound, which] is not associated with any significant adverse public health effects.”
Transparency: Moon Mother sends each batch of product to a third-party lab to be tested for potency as well as other contaminants. You can find all of these lab reports on the company’s website. They also added more information about their company processes to the website, so it’s easier to find important information about extraction and manufacturing.
There truly is no one-size-fits-all serving size, but for those just starting out, the best rule of thumb is to start low and slow. Start with just two to three milligrams and work your way up. This may take some trial and error, but you certainly don’t want to go too hard into the deep end. Thankfully, you cannot overdose on CBD, and even the highest concentrations of pure CBD oil report no significant side effects.
Generalized pain, for instance, has dozens upon dozens of high profile research and clinical studies that have been carried out in universities and laboratories around the globe. One of the most well-publicized of these studies took place back in 2008, in which results determined that “cannabinoid analgesics (pain relievers) have generally been well tolerated in clinical trials … with acceptable adverse event profiles (meaning acceptable effectiveness for practical use).